Zusammenfassung
Psychische Komorbidität bei somatischen Erkrankungen ist oftmals mit schlechteren klinischen und psychosozialen Outcomes, Beeinträchtigungen der gesundheitsbezogenen Lebensqualität und erhöhter Leistungsinanspruchnahme assoziiert. Der vorliegende Beitrag widmet sich gesundheitsökonomischen Aspekten psychischer Komorbidität bei somatischen Krankheiten. Neben grundlegenden theoretischen und methodischen Aspekten von Krankheitskostenstudien und ökonomischen Evaluationen auf dem Gebiet der psychischen Komorbidität werden jeweils die in der internationalen Literatur verfügbaren gesundheitsökonomischen Studienergebnisse für das Beispiel der komorbiden Depression bei Diabetes mellitus vorgestellt. Die Ergebnisse zeigen, dass psychische Komorbidität mit erhöhten Behandlungskosten verbunden ist, die zumindest teilweise auf einer erhöhten Leistungsinanspruchnahme im Bereich der somatischen Versorgung beruhen. Ursache hierfür sind Wechselwirkungen zwischen der psychischen und der somatischen Erkrankung. Geeignete Interventionen können diese Zusatzkosten wahrscheinlich reduzieren und die aus dieser Intervention resultierenden Kosten eventuell sogar überkompensieren. Insgesamt besteht zu diesem Themenfeld noch erheblicher Forschungsbedarf.
Abstract
Physical-mental comorbidity is often associated with worse clinical and psychosocial outcomes, reduced health-related quality of life, and increased healthcare utilization. The following article is dedicated to the health economic aspects of physical-mental comorbidity. It presents basic theoretical and methodological aspects of cost-of-illness studies and economic evaluations related to physical-mental comorbidity, which are explained and discussed for the practical example of comorbid depression in diabetes mellitus. The results show that mental comorbidity in diabetes is associated with increased healthcare costs, which can in part be attributed to an increased somatic health service use. Appropriate interventions can lower these excess costs. Economic evaluations assessing the effectiveness of interventions for depressive diabetics have shown that overall health can be improved and costs saved. However, especially in health economics, mental comorbidity in somatic diseases has not been comprehensively investigated and further research is warranted.
Literatur
Valderas JM, Starfield B, Sibbald B et al (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7:357–363
Härter M, Baumeister H (2007) Ätiologie psychischer Störungen bei chronischen körperlichen Erkrankungen. In: Härter M, Baumeister H, Bengel J (Hrsg) Psychische Störungen bei chronischen körperlichen Erkrankungen. Springer Medizin Verlag, Heidelberg, S 1–8
Gili M, Comas A, Garcia-Garcia M et al (2010) Comorbidity between common mental disorders and chronic somatic diseases in primary care patients. Gen Hosp Psychiatry 32:240–245
Harter M, Baumeister H, Reuter K et al (2007) Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 76:354–360
Baumeister H, Härter M (2005) Auswirkungen komorbider Störungen bei chronischen körperlichen Erkrankungen. Z Med Psychol 14:1–15
Baumeister H, Balke K, Harter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100
Moussavi S, Chatterji S, Verdes E et al (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858
OECD (2010) Main economic indicators. http://stats.oecd.org
Le TK, Able SL, Lage MJ (2006) Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc 4:18
Egede LE, Zheng D, Simpson K (2002) Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25:464–470
Simon GE, Katon WJ, Lin EH et al (2005) Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 27:344–351
Finkelstein EA, Bray JW, Chen H et al (2003) Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26:415–420
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes – impact of depression symptoms on adherence, function, costs. Arch Intern Med 160:3278–3285
Nichols L, Barton PL, Glazner J, McCollum M (2007) Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc 5:4
Egede LE (2005) Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr Diabetes Rev 1:235–243
Egede LE, Ellis C, Grubaugh AL (2009) The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry 31:422–427
Subramaniam M, Sum CF, Pek E et al (2009) Comorbid depression and increased health care utilisation in individuals with diabetes. Gen Hosp Psychiatry 31:220–224
Von Korff M, Ludman E, Katon W et al (2005) Work disability among individuals with diabetes. Diabetes Care 28:1326–1332
Egede LE, Ellis C (2008) The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes. Diabetes Technol Ther 10:213–219
Petrak F, Herpertz S (2009) Treatment of depression in diabetes: an update. Curr Opin Psychiatry 22:211–217
Katon W, Unutzer J, Fan MY et al (2006) Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29:265–270
Simon GE, Katon WJ, Lin EHB et al (2007) Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 64:65–72
Katon WJ, Russo JE, Von Korff M et al (2008) Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care 31:1155–1159
Luppa M, Heinrich S, Matschinger H et al (2008) Direct costs associated with depression in old age in Germany. J Affect Disord 105:195–204
Rowan PJ, Davidson K, Campbell JA et al (2002) Depressive symptoms predict medical care utilization in a population-based sample. Psychol Med 32:903–908
Arnow BA, Blasey CM, Lee J et al (2009) Relationships among depression, chronic pain, chronic disabling pain, and medical costs. Psychiatr Serv 60:344–350
Sayers SL, Hanrahan N, Kutney A et al (2007) Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J Am Geriatr Soc 55:1585–1591
Johansson PA, Farup PG, Bracco A, Vandvik PO (2010) How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol 10
Fagiolini A, Goracci A (2009) The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 70:22–29
Egede LE, Ellis C (2010) Diabetes and depression: global perspectives. Diabetes Res Clin Pract 87:302–312
Vamos EP, Mucsi I, Keszei A et al (2009) Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey. Psychosom Med 71:501–507
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078
Diabetes DE (2010) Deutscher Gesundheitsbericht Diabetes 2010. Kirchheim, Mainz
Lustman PJ, Anderson RJ, Freedland KE et al (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942
Groot M de, Anderson R, Freedland KE et al (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630
Von Korff M, Katon W, Lin EH et al (2005) Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med 67:233–240
Egede LE (2004) Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27:421–428
Schram MT, Baan CA, Pouwer F (2009) Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) Research Consortium. Curr Diabetes Rev 5:112–119
Katon W, Fan MY, Unutzer J et al (2008) Depression and diabetes: a potentially lethal combination. J Gen Intern Med 23:1571–1575
Lin EH, Heckbert SR, Rutter CM et al (2009) Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 7:414–421
Katon WJ, Simon G, Russo J et al (2004) Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 42:1222–1229
Danksagung
Diese Arbeit wurde vom Bundesministerium für Bildung und Forschung gefördert (Förderkennzeichen 01ET0728 und 01ET0719).
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehnert, T., Konnopka, A., Riedel-Heller, S. et al. Gesundheitsökonomische Aspekte psychischer Komorbidität bei somatischen Krankheiten. Bundesgesundheitsbl. 54, 120–127 (2011). https://doi.org/10.1007/s00103-010-1187-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-010-1187-8